Literature DB >> 8646415

Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices.

T Frankiewicz1, B Potier, Z I Bashir, G L Collingridge, C G Parsons.   

Abstract

The effects of the uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonists, memantine (1-amino-3,5-dimethyladamantane) and MK-801 ((+)-5-methyl-10,11-dihydro-5H-dibenzocyclo-hepten-5,10-imin e maleate) were compared on synaptic transmission and long-term potentiation (LTP) in hippocampal slices and on NMDA-induced currents in cultured superior collicular neurones. 2. Memantine (10-100 microM) reversibly reduced, but did not abolish, NMDA receptor-mediated secondary population spikes recorded in area CA1 of hippocampal slices bathed in Mg(2+)-free artificial cerebrospinal fluid. 3. Memantine (100 microM) antagonized NMDA receptor-mediated excitatory postsynaptic currents recorded in area CA1 in a strongly voltage-dependent manner i.e. depressed to 11 +/- 4% of control at -35 mV and 95 +/- 5% of control at +40 mV (n = 9), with no apparent effect on response kinetics. 4. The effects of MK-801 and memantine on the induction of LTP were assessed after prolonged pre-incubations with these antagonists. When present for 6.6 +/- 0.4 h prior to tetanic stimulation, memantine blocked the induction of LTP with an IC50 of 11.6 +/- 0.53 microM. By comparison, similar long pre-incubations with MK-801 (6.4 +/- 0.4 h) blocked the induction of LTP with an IC50 of 0.13 +/- 0.02 microM. 5. Memantine and MK-801 reduced NMDA-induced currents in cultured superior colliculus neurones recorded at -70 mV with IC50s of 2.2 +/- 0.2 microM and 0.14 +/- 0.04 microM respectively. The effects of memantine were highly voltage-dependent and behaved as though the affinity decreased epsilon fold per 50 mV of depolarization (apparent delta = 0.71). In contrast, under the conditions used, MK-801 appeared to be much less voltage-dependent i.e. affinity decreased epsilon fold per 329 mV of depolarization (apparent delta = 0.15). 6. Depolarizing steps from -70 mV to +50 mV in the continuous presence of memantine (10 microM) caused a rapid relief of blockade of NMDA-induced currents from 83.7 +/- 1.9% to 21.8 +/- 1.8% (n = 5). This relief was best fitted by a double exponential function (17.2 +/- 11.7 and 698 +/- 204 ms), the faster component of which was most pronounced. 7. In conclusion, whereas MK-801 is equipotent in blocking NMDA-induced currents (at - 70 mV) and the induction of LTP, memantine is relatively less potent in blocking the induction of LTP. This is due to its rapid relief of blockade upon depolarization; a property which might explain its promising clinical profile in the treatment of chronic neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8646415      PMCID: PMC1909336          DOI: 10.1111/j.1476-5381.1996.tb15245.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  49 in total

1.  MK-801 blocks NMDA receptor-mediated synaptic transmission and long term potentiation in rat hippocampal slices.

Authors:  E J Coan; W Saywood; G L Collingridge
Journal:  Neurosci Lett       Date:  1987-09-11       Impact factor: 3.046

2.  Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis.

Authors:  M Y Globus; R Busto; W D Dietrich; E Martinez; I Valdes; M D Ginsberg
Journal:  J Neurochem       Date:  1988-11       Impact factor: 5.372

3.  [Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study].

Authors:  E Schneider; P A Fischer; R Clemens; F Balzereit; E W Fünfgeld; H J Haase
Journal:  Dtsch Med Wochenschr       Date:  1984-06-22       Impact factor: 0.628

4.  Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.

Authors:  J Kornhuber; J Bormann; M Hübers; K Rusche; P Riederer
Journal:  Eur J Pharmacol       Date:  1991-04-25       Impact factor: 4.432

5.  Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones.

Authors:  M L Mayer; G L Westbrook; P B Guthrie
Journal:  Nature       Date:  1984 May 17-23       Impact factor: 49.962

6.  Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischemia.

Authors:  A Buisson; J Callebert; E Mathieu; M Plotkine; R G Boulu
Journal:  J Neurochem       Date:  1992-09       Impact factor: 5.372

7.  NMDA Receptor-dependent Transient Homo- and Heterosynaptic Depression in Picrotoxin-treated Hippocampal Slices.

Authors:  Zafar I. Bashir; Graham L. Collingridge
Journal:  Eur J Neurosci       Date:  1992       Impact factor: 3.386

8.  Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats?--case of amantadine and memantine.

Authors:  W Danysz; M Gossel; W Zajaczkowski; D Dill; G Quack
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1994

9.  Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat.

Authors:  G L Wenk; W Danysz; S L Mobley
Journal:  Brain Res       Date:  1994-08-29       Impact factor: 3.252

10.  Differences in results from in vivo and in vitro studies on the use-dependency of N-methylaspartate antagonism by MK-801 and other phencyclidine receptor ligands.

Authors:  S N Davies; D Martin; J D Millar; J A Aram; J Church; D Lodge
Journal:  Eur J Pharmacol       Date:  1988-01-12       Impact factor: 4.432

View more
  35 in total

1.  Timosaponin derivative YY-23 acts as a non-competitive NMDA receptor antagonist and exerts a rapid antidepressant-like effect in mice.

Authors:  Qi Zhang; Fei Guo; Zhi-wen Fu; Bing Zhang; Cheng-gang Huang; Yang Li
Journal:  Acta Pharmacol Sin       Date:  2015-12-21       Impact factor: 6.150

2.  Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice.

Authors:  Hongxin Dong; Maureen V Martin; Shawn Chambers; John G Csernansky
Journal:  J Comp Neurol       Date:  2007-01-10       Impact factor: 3.215

Review 3.  NMDA receptor as a newly identified member of the metabotropic glutamate receptor family: clinical implications for neurodegenerative diseases.

Authors:  ChiHye Chung
Journal:  Mol Cells       Date:  2013-06-04       Impact factor: 5.034

4.  Effects of Mg2+ on recovery of NMDA receptors from inhibition by memantine and ketamine reveal properties of a second site.

Authors:  Nathan G Glasgow; Madeleine R Wilcox; Jon W Johnson
Journal:  Neuropharmacology       Date:  2018-05-12       Impact factor: 5.250

Review 5.  Alzheimer's disease amyloid beta-protein and synaptic function.

Authors:  Tomas Ondrejcak; Igor Klyubin; Neng-Wei Hu; Andrew E Barry; William K Cullen; Michael J Rowan
Journal:  Neuromolecular Med       Date:  2009-09-16       Impact factor: 3.843

6.  An N-methyl-D-aspartate receptor channel blocker with neuroprotective activity.

Authors:  K K Tai; S E Blondelle; J M Ostresh; R A Houghten; M Montal
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

7.  Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.

Authors:  I Bresink; T A Benke; V J Collett; A J Seal; C G Parsons; J M Henley; G L Collingridge
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

8.  Chronic memantine does not block 3-nitropropionic acid-delayed ischaemic tolerance in rat hippocampal slices ex vivo.

Authors:  Tadeusz Frankiewicz; Chris G Parsons
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 9.  The role of the N-methyl-D-aspartate receptor in Alzheimer's disease: therapeutic potential.

Authors:  P Murali Doraiswamy
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

10.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.